Literature DB >> 16626031

Human polyomavirus JC and BK persistent infection.

Kristina Doerries1.   

Abstract

Primary contact with the human polyomaviruses (HPV) is followed by lifelong persistence of viral DNA in its host. The most prominent organs affected are the kidney, the Central Nervous System (CNS)and the hematopoietic system. Under impairment of immune competence limited activation of virus infection can be followed by prolonged virus multiplication, severe destruction of tissue and disease. The mechanisms responsible for activation episodes of the asymptomatic persistent infection are not understood and questions on cellular localization, routes of dissemination of HPV infection and its activation are controversially discussed. The type of interaction of HPVs with target organs and patients groups is highly differentiated. Organ-specific activation above basic level argues for strong dependence on the respective immune states of risk group patients. However, since immune impairment generally plays an important role in the activation of polyomavirus infection, amplification of virus deoxyribonucleic acid (DNA) and activation of virus replication is also a normal event that is probably subject to immunomodulation in the healthy individual. It also becomes clear that BKV and JCV infection is differentially regulated by mechanisms depending on the balance of immune control as well as on organ-specific signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626031     DOI: 10.1007/0-387-32957-9_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  34 in total

Review 1.  BK polyomavirus: emerging pathogen.

Authors:  Shauna M Bennett; Nicole M Broekema; Michael J Imperiale
Journal:  Microbes Infect       Date:  2012-02-24       Impact factor: 2.700

2.  Comparison of anti-reflux mechanism between Double-J-Stent and standart Double-J-Stent use for risk of BK nephropathy and urinary tract Infection in kidney transplantation.

Authors:  Nurettin Ay; Mehmet Veysi Bahadır; Melih Anıl; Vahhac Alp; Şafak Kaya; Utkan Sevük; Mesut Gül; Ramazan Danış
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Role of SV40 ST antigen in the persistent infection of mesothelial cells.

Authors:  Kelly M Fahrbach; Rebecca B Katzman; Kathleen Rundell
Journal:  Virology       Date:  2007-10-23       Impact factor: 3.616

4.  The role of the medical librarian in the basic biological sciences: a case study in virology and evolution.

Authors:  Michele R Tennant; Michael M Miyamoto
Journal:  J Med Libr Assoc       Date:  2008-10

5.  JC virus infection: a cause of colorectal cancer?

Authors:  Dana E Rollison
Journal:  J Clin Gastroenterol       Date:  2010-08       Impact factor: 3.062

6.  JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.

Authors:  Etty Kruzel-Davila; Jasmin Divers; Gregory B Russell; Zipi Kra-Oz; Moran Szwarcwort Cohen; Carl D Langefeld; Lijun Ma; Douglas S Lyles; Pamela J Hicks; Karl L Skorecki; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

7.  Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance.

Authors:  Shimon Kusne; Regis A Vilchez; Preeti Zanwar; Jorge Quiroz; Marek J Mazur; Raymond L Heilman; David Mulligan; Janet S Butel
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

Review 8.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

Review 9.  JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

Authors:  Tatiana R Coelho; Luis Almeida; Pedro A Lazo
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

10.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.